# Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product

> **NCT01084603** · NA · COMPLETED · sponsor: **McNeil AB** · enrollment: 45 (actual)

## Conditions studied

- Tobacco Dependence

## Interventions

- **DRUG:** Oral Nicotine
- **DRUG:** NiQuitinTM Nicotine Lozenge
- **DRUG:** Nicorette® Nicotine Gum

## Key facts

- **NCT ID:** NCT01084603
- **Lead sponsor:** McNeil AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-05
- **Final completion:** 2009-06
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2012-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01084603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01084603, "Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01084603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*